Passage BIO (PASG) Other Accumulated Expenses (2019 - 2024)

Passage BIO's Other Accumulated Expenses history runs 6 years deep, the most recent figure standing at $2.0 million for Q1 2024.

• In Q1 2024, Other Accumulated Expenses fell 50.0% year-over-year to $2.0 million; the TTM figure through Mar 2024 stood at $2.0 million (down 50.0% YoY), while the FY2023 annual figure was $2.0 million, changed N/A from the prior year.
• Other Accumulated Expenses for Q1 2024 stood at $2.0 million, roughly flat from $2.0 million in the prior quarter.
• The five-year high for Other Accumulated Expenses was $5.0 million in Q2 2023, with the low at $18000.0 in Q1 2020.
• The 5-year median for Other Accumulated Expenses is $1.6 million (2021), against an average of $1.7 million.
• The sharpest annual moves came in 2021 and 2024: Other Accumulated Expenses soared 11011.11% in 2021, then plunged 50.0% in 2024.
• Passage BIO's Other Accumulated Expenses stood at $541000.0 in 2020, then slipped by 7.58% to $500000.0 in 2021, then gained by 14.2% to $571000.0 in 2022, then soared by 250.26% to $2.0 million in 2023, then changed by 0.0% to $2.0 million in 2024.
• Business Quant data shows PASG's Other Accumulated Expenses at $2.0 million in Q1 2024, $2.0 million in Q4 2023, and $4.0 million in Q3 2023.